Artículos de revistas sobre el tema "DEPDC1A"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "DEPDC1A".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Kassambara, Alboukadel, Matthieu Schoenhals, Jérôme Moreaux, Jean-Luc Veyrune, Thierry Rème, Hartmut Goldschmidt, Dirk Hose y Bernard Klein. "Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells". PLoS ONE 8, n.º 4 (30 de abril de 2013): e62752. http://dx.doi.org/10.1371/journal.pone.0062752.
Texto completoXu, Wei, Juan Wang, Jinfu Xu, Shenyi Li, Ranran Zhang, Cong Shen, Min Xie, Bo Zheng y Menghui Gu. "Long non-coding RNA DEPDC1-AS1 promotes proliferation and migration of human gastric cancer cells HGC-27 via the human antigen R–F11R pathway". Journal of International Medical Research 50, n.º 4 (abril de 2022): 030006052210931. http://dx.doi.org/10.1177/03000605221093135.
Texto completoXu, Wei, Juan Wang, Jinfu Xu, Shenyi Li, Ranran Zhang, Cong Shen, Min Xie, Bo Zheng y Menghui Gu. "Long non-coding RNA DEPDC1-AS1 promotes proliferation and migration of human gastric cancer cells HGC-27 via the human antigen R–F11R pathway". Journal of International Medical Research 50, n.º 4 (abril de 2022): 030006052210931. http://dx.doi.org/10.1177/03000605221093135.
Texto completoHu, Feng, Ki On Fong, May P. L. Cheung, Jessica A. J. Liu, Rui Liang, Tsz Wai Li, Rakesh Sharma, Philip P. C. Ip, Xintao Yang y Martin Cheung. "Abstract 5971: DEPDC1B promotes melanoma angiogenesis and metastasis through sequestration of ubiquitin ligase CDC16 to stabilize secreted SCUBE3". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5971. http://dx.doi.org/10.1158/1538-7445.am2022-5971.
Texto completoAhuja, Palak y Kailash Singh. "In Silico Approach for SAR Analysis of the Predicted Model of DEPDC1B: A Novel Target for Oral Cancer". Advances in Bioinformatics 2016 (29 de febrero de 2016): 1–8. http://dx.doi.org/10.1155/2016/3136024.
Texto completoLou, Tingting, Luqing Zhang, Zongshan Jin, Chundi Miao, Jinqiu Wang y Kongliang Ke. "miR-455-5p enhances 5-fluorouracil sensitivity in colorectal cancer cells by targeting PIK3R1 and DEPDC1". Open Medicine 17, n.º 1 (1 de enero de 2022): 847–56. http://dx.doi.org/10.1515/med-2022-0474.
Texto completoHuang, Guangzhao, Su Chen, Jumpei Washio, Grace Paka Paka Lubamba, Nobuhiro Takahashi y Chunjie Li. "Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway". International Journal of Molecular Sciences 24, n.º 3 (19 de enero de 2023): 1992. http://dx.doi.org/10.3390/ijms24031992.
Texto completoBin, Xiaoyun, Zongjiang Luo, Jianchu Wang y Sufang Zhou. "Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma". Computational and Mathematical Methods in Medicine 2023 (2 de febrero de 2023): 1–17. http://dx.doi.org/10.1155/2023/8958962.
Texto completoPang, Yuzhi, Feifei Xie, Hui Cao, Chunmeng Wang, Meijun Zhu, Xiaoxiao Liu, Xiaojing Lu et al. "Mutational inactivation of mTORC1 repressor gene DEPDC5 in human gastrointestinal stromal tumors". Proceedings of the National Academy of Sciences 116, n.º 45 (21 de octubre de 2019): 22746–53. http://dx.doi.org/10.1073/pnas.1914542116.
Texto completoMotomura, Takashi, Yuki Ono, Ken Shirabe, Takasuke Fukuhara, Hideyuki Konishi, Yohei Mano, Takeo Toshima et al. "Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy". HPB Surgery 2012 (24 de octubre de 2012): 1–6. http://dx.doi.org/10.1155/2012/185496.
Texto completoZhao, Yanting, Helen Zhang, Jack M. Parent y Lori L. Isom. "4346 Potential Sudden Unexpected Death in Epilepsy (SUDEP) Biomarkers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes with DEPDC5 Loss-of-Function". Journal of Clinical and Translational Science 4, s1 (junio de 2020): 100. http://dx.doi.org/10.1017/cts.2020.311.
Texto completoYuskaitis, Christopher J., Leigh-Ana Rossitto, Sarika Gurnani, Elizabeth Bainbridge, Annapurna Poduri y Mustafa Sahin. "Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice". Human Molecular Genetics 28, n.º 17 (17 de mayo de 2019): 2952–64. http://dx.doi.org/10.1093/hmg/ddz123.
Texto completoKlofas, Lindsay K., Brittany P. Short, Chengwen Zhou y Robert P. Carson. "Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1". Human Molecular Genetics 29, n.º 8 (13 de abril de 2020): 1365–77. http://dx.doi.org/10.1093/hmg/ddaa068.
Texto completoGarcia-Mata, Rafael. "Arrested Detachment: A DEPDC1B-Mediated De-adhesion Mitotic Checkpoint". Developmental Cell 31, n.º 4 (noviembre de 2014): 387–89. http://dx.doi.org/10.1016/j.devcel.2014.11.008.
Texto completoFarhan, Hanan, Khadiga Abougabal, Heba Gaber y Dina Attia. "Disheveled EGL-10 and pleckstrin domain-containing 5 rs1012068 T/G gene polymorphism among Egyptian chronic HCV-infected patients: disease progression and related complications". Egyptian journal of Immunology 29 (1 de julio de 2022): 36–43. http://dx.doi.org/10.55133/eji.290305.
Texto completoPadi, Sathish K. R., Neha Singh, Jeremiah J. Bearss, Virginie Olive, Jin H. Song, Marina Cardó-Vila, Andrew S. Kraft y Koichi Okumura. "Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth". Proceedings of the National Academy of Sciences 116, n.º 41 (23 de septiembre de 2019): 20505–10. http://dx.doi.org/10.1073/pnas.1904774116.
Texto completoObara, Wataru. "Adjuvant cancer peptide vaccine treatment with intravesical BCG therapy for non-muscle-invasive bladder cancer." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e15587-e15587. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e15587.
Texto completoJansen, Laura A. "Delving Deeper into DEPDC5". Epilepsy Currents 18, n.º 3 (1 de mayo de 2018): 197–99. http://dx.doi.org/10.5698/1535-7597.18.3.197.
Texto completoLi, Pulin, Xiaojuan Chen, Sijing Zhou, Xingyuan Xia, Enze Wang, Rui Han, Daxiong Zeng, Guanghe Fei y Ran Wang. "High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma". Journal of Inflammation Research Volume 15 (julio de 2022): 4171–84. http://dx.doi.org/10.2147/jir.s369219.
Texto completoDang, Xiao-Wei, Qi Pan, Zhen-Hai Lin, Hao-Hao Wang, Lu-Hao Li, Lin Li, Dong-Qi Shen y Pei-Ju Wang. "Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1". Aging 13, n.º 16 (25 de mayo de 2021): 20094–115. http://dx.doi.org/10.18632/aging.203016.
Texto completoMarchesi, Stefano, Francesca Montani, Gianluca Deflorian, Rocco D’Antuono, Alessandro Cuomo, Serena Bologna, Carmela Mazzoccoli, Tiziana Bonaldi, Pier Paolo Di Fiore y Francesco Nicassio. "DEPDC1B Coordinates De-adhesion Events and Cell-Cycle Progression at Mitosis". Developmental Cell 31, n.º 4 (noviembre de 2014): 420–33. http://dx.doi.org/10.1016/j.devcel.2014.09.009.
Texto completoIGASE, Masaya, Yuki MORINAGA, Masahiro KATO, Toshihiro TSUKUI, Yusuke SAKAI, Masaru OKUDA y Takuya MIZUNO. "Establishment of rat anti-canine DEP domain containing 1B (DEPDC1B) monoclonal antibodies". Journal of Veterinary Medical Science 82, n.º 4 (2020): 483–87. http://dx.doi.org/10.1292/jvms.19-0667.
Texto completoSamanta, Debopam. "DEPDC5-related epilepsy: A comprehensive review". Epilepsy & Behavior 130 (mayo de 2022): 108678. http://dx.doi.org/10.1016/j.yebeh.2022.108678.
Texto completoFeng, Xuefei, Chundong Zhang, Ling Zhu, Lian Zhang, Hongxia Li, Longxia He, Yan Mi, Yitao Wang, Jiang Zhu y Youquan Bu. "DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma". Oncotarget 8, n.º 38 (29 de junio de 2017): 63605–19. http://dx.doi.org/10.18632/oncotarget.18868.
Texto completoMi, Yan, Chundong Zhang, Youquan Bu, Ying Zhang, Longxia He, Hongxia Li, Huifang Zhu, Yi Li, Yunlong Lei y Jiang Zhu. "DEPDC1 is a novel cell cycle related gene that regulates mitotic progression". BMB Reports 48, n.º 7 (31 de julio de 2015): 413–18. http://dx.doi.org/10.5483/bmbrep.2015.48.7.036.
Texto completoKikuchi, Ryogo, Masahiro Toda, Oltea Sampetrean, Hideyuki Saya y Kazunari Yoshida. "CBIO-17EXPRESSION AND FUNCTIONAL ANALYSIS OF AN ONCOANTIGEN, DEPDC1, IN MALIGNANT GLIOMA". Neuro-Oncology 17, suppl 5 (noviembre de 2015): v58.3—v58. http://dx.doi.org/10.1093/neuonc/nov209.17.
Texto completoWang, Wei, Aili Li, Xiaodan Han, Qingqing Wang, Jinyong Guo, Youru Wu, Chen Wang y Guojin Huang. "DEPDC1 up‐regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells". Journal of Cellular and Molecular Medicine 24, n.º 22 (5 de octubre de 2020): 13303–13. http://dx.doi.org/10.1111/jcmm.15947.
Texto completoKanehira, M., Y. Harada, R. Takata, T. Shuin, T. Miki, T. Fujioka, Y. Nakamura y T. Katagiri. "Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis". Oncogene 26, n.º 44 (23 de abril de 2007): 6448–55. http://dx.doi.org/10.1038/sj.onc.1210466.
Texto completoWeston, Matthew. "Getting Sucker Punched by Depdc5 Really Hurts". Epilepsy Currents 20, n.º 6 (14 de septiembre de 2020): 378–80. http://dx.doi.org/10.1177/1535759720956992.
Texto completoChen, Dan, Satoko Ito, Toshinori Hyodo, Eri Asano-Inami, Hong Yuan y Takeshi Senga. "Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis". Experimental Cell Research 358, n.º 2 (septiembre de 2017): 101–10. http://dx.doi.org/10.1016/j.yexcr.2017.06.005.
Texto completoRamalho-Carvalho, João, João Barbosa Martins, Lina Cekaite, Anita Sveen, Jorge Torres-Ferreira, Inês Graça, Pedro Costa-Pinheiro et al. "Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1". Cancer Letters 385 (enero de 2017): 150–59. http://dx.doi.org/10.1016/j.canlet.2016.10.028.
Texto completoKikuchi, Ryogo, Oltea Sampetrean, Hideyuki Saya, Kazunari Yoshida y Masahiro Toda. "Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells". Journal of Neuro-Oncology 133, n.º 2 (29 de mayo de 2017): 297–307. http://dx.doi.org/10.1007/s11060-017-2457-1.
Texto completoTsai, M. H., C. K. Chan, Y. C. Chang, Y. T. Yu, S. T. Chuang, W. L. Fan, S. C. Li et al. "DEPDC5 mutations in familial and sporadic focal epilepsy". Clinical Genetics 92, n.º 4 (30 de marzo de 2017): 397–404. http://dx.doi.org/10.1111/cge.12992.
Texto completoMyers, Kenneth A. y Ingrid E. Scheffer. "DEPDC5 as a potential therapeutic target for epilepsy". Expert Opinion on Therapeutic Targets 21, n.º 6 (13 de abril de 2017): 591–600. http://dx.doi.org/10.1080/14728222.2017.1316715.
Texto completoMarsan, Elise, Saeko Ishida, Adrien Schramm, Sarah Weckhuysen, Giuseppe Muraca, Sarah Lecas, Ning Liang et al. "Depdc5 knockout rat: A novel model of mTORopathy". Neurobiology of Disease 89 (mayo de 2016): 180–89. http://dx.doi.org/10.1016/j.nbd.2016.02.010.
Texto completoIshida, Saeko. "DEPDC5, a new key to understand various epilepsies". Folia Pharmacologica Japonica 152, n.º 6 (2018): 281–85. http://dx.doi.org/10.1254/fpj.152.281.
Texto completoIshida, Saeko, Fabienne Picard, Gabrielle Rudolf, Eric Noé, Guillaume Achaz, Pierre Thomas, Pierre Genton et al. "Mutations of DEPDC5 cause autosomal dominant focal epilepsies". Nature Genetics 45, n.º 5 (31 de marzo de 2013): 552–55. http://dx.doi.org/10.1038/ng.2601.
Texto completoYang, Mian, Haibin He, Tao Peng, Yi Lu y Jiazi Yu. "Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma". Computational Intelligence and Neuroscience 2022 (29 de marzo de 2022): 1–15. http://dx.doi.org/10.1155/2022/8598046.
Texto completoTosi, Anna, Silvia Dalla Santa, Elisa Cappuzzello, Carolina Marotta, Dawid Walerich, Giannino Del Sal, Paola Zanovello, Roberta Sommaggio y Antonio Rosato. "Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1". OncoImmunology 6, n.º 8 (5 de abril de 2017): e1313371. http://dx.doi.org/10.1080/2162402x.2017.1313371.
Texto completoHarada, Yosuke, Mitsugu Kanehira, Yoshiko Fujisawa, Ryo Takata, Taro Shuin, Tsuneharu Miki, Tomoaki Fujioka, Yusuke Nakamura y Toyomasa Katagiri. "Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells". Cancer Research 70, n.º 14 (29 de junio de 2010): 5829–39. http://dx.doi.org/10.1158/0008-5472.can-10-0255.
Texto completoSendoel, Ataman, Simona Maida, Xue Zheng, Youjin Teo, Lilli Stergiou, Carlo-Alberto Rossi, Deni Subasic et al. "DEPDC1/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis". Nature Cell Biology 16, n.º 8 (27 de julio de 2014): 812–20. http://dx.doi.org/10.1038/ncb3010.
Texto completoHuang, Lin, Keng Chen, Zhao-peng Cai, Fu-chao Chen, Hui-yong Shen, Wei-hua Zhao, Song-jie Yang, Xu-biao Chen, Guo-xue Tang y Xi Lin. "DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer". Biochemical and Biophysical Research Communications 490, n.º 3 (agosto de 2017): 707–12. http://dx.doi.org/10.1016/j.bbrc.2017.06.105.
Texto completoJia, Boquan, Jun Liu, Xin Hu, Lu Xia y Ying Han. "Pan-cancer analysis of DEPDC1 as a candidate prognostic biomarker and associated with immune infiltration". Annals of Translational Medicine 10, n.º 24 (diciembre de 2022): 1355. http://dx.doi.org/10.21037/atm-22-5598.
Texto completoCui, Feilun, Jiangpeng Hu, Jian Tan y Huaming Tang. "AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer". Translational Andrology and Urology 6, S3 (agosto de 2017): AB079. http://dx.doi.org/10.21037/tau.2017.s079.
Texto completoHu, Feng, Ki On Fong, May Pui Lai Cheung, Jessica Aijia Liu, Rui Liang, Tsz Wai Li, Rakesh Sharma, Philip Pun‐Ching IP, Xintao Yang y Martin Cheung. "DEPDC1B Promotes Melanoma Angiogenesis and Metastasis through Sequestration of Ubiquitin Ligase CDC16 to Stabilize Secreted SCUBE3". Advanced Science 9, n.º 10 (27 de enero de 2022): 2105226. http://dx.doi.org/10.1002/advs.202105226.
Texto completoXu, Yu, Wei Sun, Biqiang Zheng, Xin Liu, Zhiguo Luo, Yunyi Kong, Midie Xu y Yong Chen. "DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis". Experimental Cell Research 379, n.º 1 (junio de 2019): 48–54. http://dx.doi.org/10.1016/j.yexcr.2019.03.021.
Texto completoVan ’t Hof, Femke y Eva Brilstra. "Focale epilepsie en de GATOR1 complex genen". Epilepsie, periodiek voor professionals 19, n.º 2 (1 de junio de 2021): 11–13. http://dx.doi.org/10.54160/epilepsie.11027.
Texto completoArenas-Cabrera, Carmen, Pablo Baena-Palomino, Javier Sánchez-García, María Oliver-Romero, Yamin Chocrón-González y Manuel Caballero-Martínez. "Sleep-related hypermotor epilepsy with genetic diagnosis: description of a case series in a tertiary referral hospital". Journal of Central Nervous System Disease 14 (enero de 2022): 117957352110601. http://dx.doi.org/10.1177/11795735211060114.
Texto completoCórdova-Palomera, A., M. Fatjó-Vilas, H. Palma-Gudiel, H. Blasco-Fontecilla, O. Kebir y L. Fañanás. "Further Evidence of Depdc7 Dna Hypomethylation in Depression: a Study in Adult Twins". European Psychiatry 30, n.º 6 (4 de mayo de 2015): 715–18. http://dx.doi.org/10.1016/j.eurpsy.2015.04.001.
Texto completoAnderson, Matthew P. "DEPDC5 takes a second hit in familial focal epilepsy". Journal of Clinical Investigation 128, n.º 6 (30 de abril de 2018): 2194–96. http://dx.doi.org/10.1172/jci121052.
Texto completo